Join us at our Antwerp Laboratory to discover how advanced multimodal platforms are revolutionizing clinical biomarker research to advance drug discovery.

Explore how innovative technologies including Biofidelity’s ASPYRE and ENSPYRE assays, Lunaphore’s high-multiplex immunofluorescence and Lunit’s digital pathology platform are driving advancements in clinical research. Hear from our expert speakers as they share case studies and insights into technical applications of these cutting-edge platforms.

Through technical discussions and real-world case studies, this workshop will demonstrate how a multimodal approach to clinical biomarkers accelerates the drug development process and maximizes each sample.

Joining us:

What to expect:

• Subject matter experts from biopharmaceutical companies, technology providers, and CellCarta’s own scientists.
• Insights into emerging technologies in liquid biopsy, spatial biology, digital pathology
• Meet others applying cutting edge technologies to their development programs
• Behind the scenes visit to our CRO laboratory

Key topics:

ASPYRE & ENSPYRE: fast, ultra-sensitive, and cost-effective molecular testing for patient selection, MRD and monitoring

Speakers: Biofidelity; CellCarta

Revealing tissue architecture and biomarker landscapes: Spatial biology with multiplex immunofluorescence 

Speakers: Biotechne/Lunaphore; CellCarta

AI-Powered Digital Pathology Analysis for Biomarker Identification 

Speakers: Lunit; CellCarta

Circulating Tumor Cells in Peripheral Blood: Simple and Convenient Liquid Biopsy 

Speakers: RareCyte; CellCarta